Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Claya vs EverSlim

Claya
Graded #264

Lower grade

vs+10.700000000000003
EverSlim
Graded #68

Higher grade

The verdict

EverSlim takes it — 73.5/100 to 62.8/100.

EverSlim grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. EverSlim is a US telehealth programme selling doctor-prescribed compounded GLP-1 medication delivered to the door, with compounded semaglutide from $117 a month and compounded tirzepatide from $140 a month.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueEverSlim +38
42
80
Dose & formulationClaya +11
75
64
Clinical oversightClaya +6
82
76
Labs & monitoringEverSlim +10
53
63
FulfillmentEverSlim +30
67
97
Contract termsClaya +6
61
55
Claya · left barEverSlim · right bar

The numbers

MetricClayaEverSlim
WeighScore62.8/10073.5/100
GradeCC
Scorecard rank#264#68
Semaglutide$299/mo (compounded)$117/mo (compounded)
Tirzepatide$299/mo (compounded)$140/mo (compounded)
CoverageCoverage not publishedAll 50 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualYesInjection only
Claya

Graded #264 · C

Strengths

  • Two named licensed clinicians (Habashy, NMD MS and Barber, MD PhD) — rare transparency for compounded GLP-1
  • Two named pharmacy partners with full addresses (RedRock, UT and Healthware, KY)
  • Both injectable and oral-tablet forms offered for semaglutide and tirzepatide
  • Weight-loss money-back guarantee published on the homepage
  • Free expedited shipping included in the monthly price

Where it loses points

  • States-served list not disclosed — you must check at checkout
  • LegitScript certification status not displayed
  • Corporate legal entity not disclosed on the site or privacy policy
  • Oral compounded tablets have weaker efficacy data than injectable semaglutide
  • Intro pricing is higher at refill ($299), erasing the first-month advantage
EverSlim

Graded #68 · C

Strengths

  • Transparent flat pricing from 127 dollars a month for compounded semaglutide; medication, provider visit, and shipping included with no insurance.
  • Names its pharmacy partners (EPIQ Scripts, Foothills, Emerald) and DrTelx medical group; LegitScript-approved and NABP-accredited.
  • Available in all 50 states and DC, with asynchronous care in 44 states and live-visit access in the rest.
  • Offers both semaglutide and tirzepatide, plus care-team messaging between visits.

Where it loses points

  • No price tiers are published anywhere: /pricing is a 404, the footer pricing link is a same-page anchor, and the checkout is behind a login, so what a titrated dose costs is unknowable before signing up
  • Cancellation requires at least 72 hours' notice before the next billing date, or the subscription renews for another cycle
  • Asynchronous care covers 44 states; DC, Kansas, Louisiana, Mississippi, New Mexico, Rhode Island and West Virginia require a live video consult
  • Marketing says 'No membership' while the cancellation policy repeatedly calls it a membership and a subscription
  • Compounded semaglutide and tirzepatide are not FDA-approved finished products

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard